Skip to content
healthcare.dev

Rotarix

NDC 58160-740, Rotavirus Vaccine, Live, Oral, solution, from GlaxoSmithKline Biologicals SA.

Product NDC
58160-740
Status
Listed
Labeler
GlaxoSmithKline Biologicals SA
Dosage form
SOLUTION
Route
ORAL
Product type
VACCINE
Marketing category
BLA
Application
BLA125265
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/58160-740 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HUMAN ROTAVIRUS A TYPE G1P(8) STRAIN RIX4414 LIVE ANTIGEN1000 [CCID_50]/mL

Pharmacologic classes

Actively Acquired Immunity [PE]; Live Attenuated Rotavirus Vaccine [EPC]; Rotavirus Vaccines [CS]; Vaccines, Attenuated [CS]

Package NDCNDC-11Package
58160-740-215816007402110 APPLICATOR in 1 CARTON (58160-740-21) / 1.5 mL in 1 APPLICATOR (58160-740-02)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 58160-740 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/58160-740 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 58160-740. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.